Your browser doesn't support javascript.
loading
Reduced prophylactic effect of tixagevimab-cilgavimab in patients with hematological malignancies and without antibody response after SARS-COV-2 vaccination.
Callegari, Chiara; Lazzarotto, Davide; Soravia, Alessandra; Mutti, Martina; Lauzzana, Pietro; Peghin, Maddalena; Cordella, Stefano; Fanin, Renato; Candoni, Anna.
Afiliação
  • Callegari C; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Lazzarotto D; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Soravia A; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Mutti M; Division of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Lauzzana P; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Peghin M; Division of Infectious Diseases, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Cordella S; Division of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Fanin R; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Candoni A; Division of Hematology and Stem Cell Transplantation Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Eur J Haematol ; 111(4): 668-670, 2023 10.
Article em En | MEDLINE | ID: mdl-37461815

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / COVID-19 Limite: Humans Idioma: En Revista: Eur J Haematol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / COVID-19 Limite: Humans Idioma: En Revista: Eur J Haematol Ano de publicação: 2023 Tipo de documento: Article